Settings
PFE [NYSE]
Pfizer Inc.
IndexDJIA S&P500 P/E19.72 EPS (ttm)1.62 Insider Own0.02% Shs Outstand6.30B Perf Week-2.11%
Market Cap201.31B Forward P/E14.50 EPS next Y2.20 Insider Trans-7.78% Shs Float6.30B Perf Month0.95%
Income10.46B PEG13.84 EPS next Q0.53 Inst Own72.00% Short Float1.04% Perf Quarter11.01%
Sales50.05B P/S4.02 EPS this Y37.50% Inst Trans0.08% Short Ratio2.64 Perf Half Y9.34%
Book/sh12.32 P/B2.59 EPS next Y-2.17% ROA7.40% Target Price34.41 Perf Year8.71%
Cash/sh5.31 P/C6.02 EPS next 5Y1.43% ROE16.60% 52W Range27.27 - 33.50 Perf YTD2.57%
Dividend1.12 P/FCF22.17 EPS past 5Y6.80% ROI10.50% 52W High-4.63% Beta0.71
Dividend %3.51% Quick Ratio2.50 Sales past 5Y1.30% Gross Margin80.70% 52W Low17.15% ATR0.72
Employees77700 Current Ratio2.90 Sales Q/Q-2.20% Oper. Margin31.90% RSI (14)47.38 Volatility2.88% 1.93%
OptionableYes Debt/Eq0.48 EPS Q/Q7.70% Profit Margin25.60% Rel Volume1.29 Prev Close32.60
ShortableYes LT Debt/Eq0.41 EarningsJan 27 BMO Payout50.70% Avg Volume24.84M Price31.95
Recom2.20 SMA20-0.79% SMA501.12% SMA2007.26% Volume31,982,004 Change-1.99%
Jan-28-15Reiterated Argus Buy $35 → $36
Dec-18-14Reiterated Deutsche Bank Buy $34 → $35
Jul-02-13Downgrade Standpoint Research Hold → Sell $24
Apr-15-13Reiterated Barclays Equal Weight $25 → $32
Jan-30-13Reiterated UBS Buy $29 → $31
Jan-30-13Reiterated Argus Buy $28 → $32
Jan-22-13Reiterated Barclays Equal Weight $24 → $25
Nov-27-12Downgrade MKM Partners Buy → Neutral $29 → $25
Oct-05-12Reiterated MKM Partners Buy $27 → $29
Nov-01-11Downgrade Standpoint Research Buy → Hold
Oct-07-11Initiated MKM Partners Buy $20.50
Sep-14-11Downgrade Barclays Capital Overweight → Equal Weight $21 → $19
Aug-10-11Upgrade Argus Hold → Buy $21
Aug-05-11Upgrade Standpoint Research Hold → Buy $21
Mar-14-11Downgrade Standpoint Research Buy → Hold
Nov-03-10Downgrade Argus Buy → Hold
May-21-10Initiated Jefferies Buy $17.80
Dec-16-09Initiated UBS Buy
Apr-27-09Initiated Standpoint Research Buy $20
Feb-12-09Upgrade Leerink Swann Mkt Perform → Outperform
Jan-28-15 02:06PM  What You Need To Know About The Spark Therapeutics IPO Benzinga
12:28PM  Pfizer Will Do Fine Without AstraZeneca at Barrons.com
11:32AM  The most important thing to look for in Amazons earnings at MarketWatch
11:01AM  Blue chip blues CNBC
10:10AM  Stock Market News for January 28, 2015 - Market News Zacks
07:00AM  Pfizer Inc. (PFE): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
12:17AM  [$$] Pfizer Hit by Stronger Dollar, Patent Losses at The Wall Street Journal
Jan-27-15 06:10PM  Drug Firms Report Good Q4, But Outlook Cloudy at Investor's Business Daily
06:06PM  Pfizer Sales Hit by Stronger Dollar at The Wall Street Journal
06:00PM  Cramer: Wouldn't you rather own a winner than a whiner? CNBC
05:34PM  Pfizer to Pay $400M to Settle Shareholder Suit Over Off-Label Marketing at The Wall Street Journal
05:25PM  Dow ends down 291 on earnings misses at USA TODAY
02:54PM  Pfizer's 2015 forecast disappoints, crimped by generics, dollar Reuters
02:47PM  Pfizer to pay $400 million to avert investor class action trial Reuters
02:39PM  Strong Dollar Means Flabby Outlook For Some Overseas at Investor's Business Daily
02:38PM  PFIZER INC (PFE) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
02:24PM  Pfizer chief says big acquisition not required at Financial Times
01:43PM  Pfizer net down on lower sales, higher research, legal costs AP
01:02PM  Pfizer's downbeat forecast CNBC
12:56PM  Pfizer Spikes On $13 Billion Plan For Buybacks, Dividends Benzinga
12:48PM  US STOCKS-Earnings trigger Wall St selloff, data weighs further Reuters
12:47PM  Analysts Weigh In On Pfizer Following Earnings Beat, Weak Forecast Benzinga
12:45PM  3M Organic Growth Solid, But Hot Dollar Saps Gains at Investor's Business Daily
12:21PM  Pfizer May Go Shopping for Growth Morningstar
12:19PM  Pfizers outlook disappoints as it struggles with patent expirations at Fortune
12:19PM  Pfizer Warns on Outlook but Analysts Optimistic: What Wall Street's Saying at TheStreet
11:57AM  Bristol, Pfizer, Novartis Forecasts Face FX Pressures at Investor's Business Daily
11:36AM  Pfizer ekes out gains on a down market day at MarketWatch
11:28AM  P&G's Revenue Falls on Stronger Dollar at The Wall Street Journal
11:24AM  Pfizer says 2015 earnings will be hurt by strong dollar at USA TODAY
11:22AM  Pfizer Discount for its Pneumococcal Vaccine is Criticized as 'Meager' at The Wall Street Journal
11:09AM  Pfizer Edges Ahead On Q4, Even As Forecast Falls Short at Barrons.com
10:51AM  Bristol-Myers Beats on Q4 Earnings, 2015 View Disappoints - Analyst Blog Zacks
10:34AM  US STOCKS-Wall St tumbles with Microsoft, Caterpillar; data weighs Reuters
10:19AM  Pfizer Beats on Q4 Earnings, Guides Below Expectations - Analyst Blog Zacks
09:49AM  Pfizer (PFE) Stock Volatile Today After Fourth-Quarter Earnings Beat, Weak 2015 Guidance at TheStreet
09:32AM  Pfizers Climb Out of 2015 Sales Ditch Means Delivering on Deal at Bloomberg
09:16AM  US STOCKS-Futures tumble with Microsoft, Caterpillar; data weighs Reuters
09:07AM  Caterpillar, P&G and Microsoft fall on disappointing results Yahoo Finance
08:43AM  PFIZER INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
08:39AM  Pfizer Sales Suffer From Patent Losses, Stronger Dollar at Forbes
08:24AM  Pfizer (PFE) Beats on Q4 Earnings, Shares Slip on Guidance - Tale of the Tape Zacks
08:20AM  Pfizer Faces Reality Check With Earnings at 24/7 Wall St.
07:34AM  Wall Street earnings woes; Durable goods; Facebook outage Yahoo Finance
07:24AM  Pfizer beats Street 4Q forecasts AP
07:15AM  Pfizer Beats Earnings Estimates as Vaccine Sales Increase at Bloomberg
07:14AM  Pfizer's stock falls after downbeat profit, sales outlook at MarketWatch
07:07AM  Q4 2014 Pfizer Inc Earnings Release - Before Market Open CCBN
07:00AM  PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2014 RESULTS; PROVIDES 2015 FINANCIAL GUIDANCE Business Wire
05:08AM  Premarkets: 5 things to know before the open at CNNMoney.com
Jan-26-15 05:10PM  Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst Blog Zacks
04:12PM  Pfizer to Cut Prevenar 13 Price Again at The Wall Street Journal
04:12PM  Pfizer Commits to Further Reduce Price for Prevenar 13 in the Worlds Poorest Countries Through 2025 Business Wire
04:00PM  Pfizer cuts vaccine price for poor as GAVI group seeks $7.5 bln Reuters
01:15PM  Jim Cramer Answers Twitter (TWTR) Questions on Johnson & Johnson, Alcoa, Mobileye, and Facebook at TheStreet
12:38PM  What to Expect When Pfizer (PFE) Reports Fourth-Quarter Earnings Tomorrow at TheStreet
08:28AM  Senator Elizabeth Warren Has Big Pharma In Her Crosshairs -- But Her Aim Is Off at Forbes
06:53AM  Regeneron vaults ahead of Amgen in race to market cholesterol drug at Fortune
Jan-25-15 09:22PM  Pfizers $33 Billion Cash Pile Has Everyone Guessing at Bloomberg
Jan-23-15 05:50PM  Will Novartis' (NVS) Earnings Disappoint Expectations in Q4? - Analyst Blog Zacks
05:07PM  FDA approves 2nd vaccine against meningitis strain AP
03:58PM  Pfizers Deal Hunt Included Rebuffed Teva Approach at Bloomberg
03:50PM  Will Oncology Products Drive Bristol-Myers (BMY) Earnings? - Analyst Blog Zacks
11:30AM  Will Pfizer (PFE) Beat Q4 Earnings Despite Generics? - Analyst Blog Zacks
08:54AM  Why Earnings Season Could Be Great for Pfizer (PFE) - Tale of the Tape Zacks
07:02AM  Dogs of the Dow can sniff out income at USA TODAY
06:15AM  Up to Speed: Death of Saudi king moves needle on oil prices (Video) at American City Business Journals
01:28AM  Davos: Why M&A won't go away at CNBC
Jan-22-15 02:06PM  An easier way to understand the pharma industry Market Realist
11:21AM  Prevenar 13®* Receives CHMP Positive Opinion For Prevention Of Vaccine-Type Pneumococcal Pneumonia in Adults Business Wire
09:30AM  Allegiant Travel, Apache, Immunomedics and Pfizer highlighted as Zacks Bull and Bear of the Day - Press Releases Zacks
08:14AM  We are funding part of ACA: Novartis CEO CNBC
Jan-21-15 04:05PM  Immunomedics Reports Data on Oncology Candidate - Analyst Blog Zacks
08:35AM  Africa's Consumer Economy at Forbes
08:19AM  The Promise Of Financial Return Is Driving Both The "Biotech Bubble" And Orphan Drugs at Forbes
Jan-20-15 06:06PM  Johnson & Johnson's forex warning a sign for rival drugmakers Reuters
05:33PM  The 5 Best Dow Stocks So Far In 2015 Benzinga
04:52PM  Bristol-Myers Names New CEO at Barrons.com
02:22PM  Vaccinating children becoming unaffordable: Report at CNBC
09:34AM  Three Stocks That Will Weather Market Volatility And Reduce Emotional Anxiety at Forbes
09:05AM  Nektar grabs more Mission Bay space on cusp of growth spurt at American City Business Journals
09:00AM  East Bay's Depomed snags J&J pain-fighting drug in $1 billion deal at American City Business Journals
04:14AM  Glaxo, Pfizer Blamed for High Prices on Vaccines in Poor Nations at Bloomberg
Jan-19-15 11:40AM  Will Pharmaceutical Segment Drive J&J Q4 Earnings Again? - Analyst Blog Zacks
08:33AM  Impact Of 'Me-Too' Drugs On Health Care Costs at Forbes
Jan-18-15 08:20AM  Merck Is Top DJIA Stock in 2015 at 24/7 Wall St.
Jan-17-15 05:00AM  Gay Marriage May Be Legal Across U.S. After Supreme Court Review Bloomberg
Jan-15-15 12:30PM  Agilent Arm/Cell Signaling Tie for Companion Diagnostics - Analyst Blog Zacks
12:01AM  Pfizer to Skip Melanoma in Bid to Join Cancer Race at Bloomberg
Jan-14-15 06:05PM  ARIAD Reveals 2015 Strategic Objectives, Updates on Pipeline - Analyst Blog Zacks
07:00AM  Leader in Genomic Sequencing Illuminates the Way Morningstar
Jan-13-15 01:36PM  Pfizer Warns U.K. Doctors About Prescribing Generic Lyrica For Pain Benzinga
10:46AM  Pfizer Warns UK Docs About Patent Infringement Over a Generic Lyrica at The Wall Street Journal
05:50AM  23andMe will offer your genetic data to researchers (with your consent) at Engadget
Jan-12-15 07:05PM  Extended-Release Drugs Get Extra Scrutiny in U.S. Quality Focus at Bloomberg
01:50PM  23andMe and Pfizer to Collaborate on Gene Database at Bloomberg
12:20PM  23andMe partners with big pharma CNBC
10:45AM  Pfizer partners with DNA research firm to study lupus disease Reuters
09:38AM  [$$] Bristol-Myers's Lung Cancer Drug Shows Success at The Wall Street Journal
08:58AM  23andMe Gives Pfizer DNA Data as Startup Seeks Growth at Bloomberg
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines, and various consumer healthcare products. The company's Primary Care segment offers prescription pharmaceutical products primarily prescribed by primary-care physicians for various therapeutic and disease areas comprising Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation. Its Specialty Care and Oncology segment provides prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. The company's Established Products and Emerging Markets segment offers prescription pharmaceutical products that had lost patent protection or marketing exclusivity in certain countries and/or regions, as well as sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. Its Consumer Healthcare segment provides non-prescription products in a range of therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company also offers Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Norvasc, Sutent, and the Premarin family of products; and consumer healthcare products under the Advil, Caltrate, Centrum, ChapStick, Emergen-C, Preparation H, and Robitussin brands. It serves wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, and grocery and convenience stores. It has strategic alliance with CliniWorks (Israel) Ltd.; and strategic collaboration with iTeos Therapeutics SA. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LANKLER DOUGLAS MExecutive Vice PresidentDec 31Option Exercise18.1921,413389,502127,673Jan 05 05:17 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerDec 31Option Exercise18.1932,120584,263207,985Jan 05 05:17 PM
HILL CHARLES HExecutive Vice PresidentDec 31Option Exercise18.1926,767486,892126,245Jan 05 05:17 PM
OLSON LAURIE JExecutive Vice PresidentDec 31Option Exercise18.1918,737340,82675,811Jan 05 05:17 PM
YOUNG JOHN DGroup PresidentDec 31Option Exercise18.1926,767486,892128,860Jan 05 05:17 PM
JOHNSON RADY AExecutive Vice PresidentDec 31Option Exercise18.1932,120584,26361,803Jan 05 05:16 PM
MADDALUNA ANTHONY JExecutive Vice PresidentDec 31Option Exercise18.1926,767486,892107,900Jan 05 05:16 PM
BOURLA ALBERTGroup PresidentDec 31Option Exercise18.1916,060292,131113,177Jan 05 05:16 PM
MADDALUNA ANTHONY JExecutive Vice PresidentDec 08Sale32.006,500208,00082,830Dec 09 10:44 AM
HILL CHARLES HExecutive Vice PresidentNov 10Sale30.188,285250,04199,478Nov 10 05:34 PM
YOUNG JOHN DGroup PresidentNov 07Option Exercise26.2021,600565,920123,462Nov 10 05:34 PM
DAMELIO FRANK AExecutive Vice PresidentNov 07Sale29.7807454,687Nov 10 05:34 PM
YOUNG JOHN DGroup PresidentNov 07Sale29.8921,600645,548101,862Nov 10 05:34 PM
READ IAN CChairman & CEOOct 30Option Exercise17.0354,585929,5831,465,906Nov 03 06:23 PM
DAMELIO FRANK AExecutive Vice PresidentOct 30Option Exercise17.0365,5021,115,499501,494Nov 03 06:23 PM
READ IAN CChairman & CEOOct 30Sale29.7667,5002,008,8001,358,862Nov 03 06:23 PM
MADDALUNA ANTHONY JExecutive Vice PresidentOct 29Sale29.562,42571,68388,987Oct 30 06:23 PM
OLSON LAURIE JExecutive Vice PresidentJun 12Option Exercise26.2036,275950,40593,010Jun 13 12:29 PM
OLSON LAURIE JExecutive Vice PresidentJun 12Sale29.5336,2751,071,27856,735Jun 13 12:29 PM
YOUNG JOHN DGroup PresidentMar 17Sale31.389,000282,42099,647Mar 18 09:33 AM
PFIZER INC10% OwnerMar 12Buy11.00272,7272,999,9971,235,330Mar 14 03:27 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale32.5967,5852,202,872173,637Mar 05 05:36 PM
Dolsten MikaelPresident R&DMar 04Sale32.5835,7891,165,929344,571Mar 05 05:36 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 04Sale32.555,082165,419171,756Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Option Exercise26.2075,5001,978,100274,699Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Sale32.0297,8613,133,674176,838Mar 05 05:37 PM
READ IAN CChairman & CEOFeb 26Option Exercise12.70324,9324,126,6361,410,536Feb 28 04:52 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise12.70130,8751,662,113312,499Feb 28 04:52 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise12.7057,586731,342116,884Feb 28 04:52 PM
BOURLA ALBERTGroup PresidentFeb 26Option Exercise12.7021,482272,82192,447Feb 28 04:52 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise12.7056,411716,420228,878Feb 28 04:52 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise12.70324,9324,126,636615,673Feb 28 04:52 PM
HILL CHARLES HExecutive Vice PresidentFeb 26Option Exercise12.7034,731441,084104,046Feb 28 04:52 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise12.7034,568439,014120,562Feb 28 04:52 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12740,480Feb 28 04:52 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12783,716Feb 28 04:52 PM
OLSON LAURIE JExecutive Vice PresidentFeb 26Option Exercise12.7031,772403,50468,167Feb 28 04:52 PM
PFIZER INC10% OwnerFeb 04Buy8.00227,2611,818,0881,794,803Feb 06 03:53 PM